VVX-004

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVVX-004
Drug Alias NameVVX-004VXX-004
ClassificationVaccines
Mechanisms of ActionImmunostimulantsT-cell surface antigen CD4 modulatorsC-C chemokine receptor type 5 modulators
TargetsT-cell surface antigen CD4C-C chemokine receptor type 5
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViravaxx Ag
China Registration ClassN/A

Develop Information

Active CompaniesViravaxx Ag
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A